From: Strategy and rationale for urine collection protocols employed in the NEPTUNE study
Visit Numbera | V1 | V2 | V3 | V4 | V5 | V6 | V7 | V8 | V9 | V10 | V11 | V12 | V13 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eligibility assessment | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Baseline H&P | Â | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Follow-up H&P | Â | Â | Â | X | X | X | X | X | X | X | X | X | X |
Biosample baseline | Â | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Biosample follow-up | Â | Â | Â | X | X | X | X | X | X | X | X | X | X |
24-hour urine | Â | X | Â | X | X | X | Â | X | Â | X | Â | X | X |
Clean catch/(Spot) urine | Â | X | Â | X | X | X | X | X | X | X | X | X | X |
Renal biopsy tissue | Â | Â | Xb | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |